Ellevest, Inc. - UROGEN PHARMA LTD ownership

UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 87 filers reported holding UROGEN PHARMA LTD in Q2 2023. The put-call ratio across all filers is 2.32 and the average weighting 0.1%.

Quarter-by-quarter ownership
Ellevest, Inc. ownership history of UROGEN PHARMA LTD
ValueSharesWeighting
Q1 2023$397
+4.2%
430.0%0.00%
Q4 2022$381
-61.9%
43
-35.8%
0.00%
Q3 2022$1,0000.0%67
-39.6%
0.00%
Q2 2022$1,000
-75.0%
111
-78.1%
0.00%
Q1 2022$4,000
+300.0%
506
+237.3%
0.00%
Q4 2021$1,000
-66.7%
150
-7.4%
0.00%
Q3 2021$3,000
+200.0%
162
+113.2%
0.00%
Q2 2021$1,0000.0%76
+123.5%
0.00%
Q1 2021$1,000340.00%
Other shareholders
UROGEN PHARMA LTD shareholders Q2 2023
NameSharesValueWeighting ↓
Wildcat Capital Management, LLC 900,148$23,512,0008.12%
Horton Capital Management, LLC 383,428$10,015,0007.55%
MENORA MIVTACHIM HOLDINGS LTD. 2,954,699$77,177,0001.89%
Phoenix Holdings Ltd. 897,464$22,251,0000.94%
SHIKIAR ASSET MANAGEMENT INC 51,175$1,337,0000.61%
Migdal Insurance & Financial Holdings Ltd. 738,302$19,284,0000.31%
Coastal Bridge Advisors, LLC 37,000$966,0000.31%
Clal Insurance Enterprises Holdings Ltd 529,388$13,828,0000.27%
ALGERT GLOBAL LLC 10,880$284,0000.10%
BANK HAPOALIM BM 14,831$387,0000.09%
View complete list of UROGEN PHARMA LTD shareholders